![Frontiers | Public and Patient Involvement in Doctoral Research During the COVID-19 Pandemic: Reflections on the Process, Challenges, Impact and Experiences From the Perspectives of Adults With Cerebral Palsy and the Doctoral Frontiers | Public and Patient Involvement in Doctoral Research During the COVID-19 Pandemic: Reflections on the Process, Challenges, Impact and Experiences From the Perspectives of Adults With Cerebral Palsy and the Doctoral](https://www.frontiersin.org/files/MyHome%20Article%20Library/874012/874012_Thumb_400.jpg)
Frontiers | Public and Patient Involvement in Doctoral Research During the COVID-19 Pandemic: Reflections on the Process, Challenges, Impact and Experiences From the Perspectives of Adults With Cerebral Palsy and the Doctoral
![Biomolecules | Free Full-Text | Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement Biomolecules | Free Full-Text | Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement](https://www.mdpi.com/biomolecules/biomolecules-11-00787/article_deploy/html/images/biomolecules-11-00787-g001.png)
Biomolecules | Free Full-Text | Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement
![Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators | Molecular Psychiatry Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators | Molecular Psychiatry](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41380-018-0206-2/MediaObjects/41380_2018_206_Fig1_HTML.png)
Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators | Molecular Psychiatry
![Abstract 18462: Proton Pump Inhibitor Use Increases the Associated Risk of First-Time Ischemic Stroke. A Nationwide Cohort Study | Circulation Abstract 18462: Proton Pump Inhibitor Use Increases the Associated Risk of First-Time Ischemic Stroke. A Nationwide Cohort Study | Circulation](https://www.ahajournals.org/cms/asset/4370e3b8-c81a-4b54-af7e-065637922b39/g18462.jpg)
Abstract 18462: Proton Pump Inhibitor Use Increases the Associated Risk of First-Time Ischemic Stroke. A Nationwide Cohort Study | Circulation
![Biomolecules | Free Full-Text | Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement Biomolecules | Free Full-Text | Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement](https://pub.mdpi-res.com/biomolecules/biomolecules-11-00787/article_deploy/html/images/biomolecules-11-00787-g002.png?1621766580)
Biomolecules | Free Full-Text | Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement
![Insights on conducting digital patient and public involvement in dementia research during the COVID-19 pandemic: supporting the development of an “E-nabling digital co-production” framework | Research Involvement and Engagement | Full Text Insights on conducting digital patient and public involvement in dementia research during the COVID-19 pandemic: supporting the development of an “E-nabling digital co-production” framework | Research Involvement and Engagement | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40900-022-00371-9/MediaObjects/40900_2022_371_Fig1_HTML.png)
Insights on conducting digital patient and public involvement in dementia research during the COVID-19 pandemic: supporting the development of an “E-nabling digital co-production” framework | Research Involvement and Engagement | Full Text
![ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet](https://www.ahajournals.org/cms/asset/4c7edbcf-4e56-4fe5-924b-0ffd78167aae/zhc0491090480001.jpeg)
ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet
Applying citizen science to engage families affected by ovarian cancer in developing genetic service outreach strategies | PLOS ONE
Insurance_post on Twitter: "Curious case of the PPI huckster filing accounts from beyond the grave https://t.co/Q2llNzR5ye" / Twitter
![Cureus | Meta-Analysis of Positive Psychology Interventions on the Treatment of Depression | Article Cureus | Meta-Analysis of Positive Psychology Interventions on the Treatment of Depression | Article](https://assets.cureus.com/uploads/figure/file/309177/lightbox_7440be706d8911ec8b16117cdebf8ee1-Figure-1c.png)
Cureus | Meta-Analysis of Positive Psychology Interventions on the Treatment of Depression | Article
![Clinical Events as a Function of Proton Pump Inhibitor Use, Clopidogrel Use, and Cytochrome P450 2C19 Genotype in a Large Nationwide Cohort of Acute Myocardial Infarction | Circulation Clinical Events as a Function of Proton Pump Inhibitor Use, Clopidogrel Use, and Cytochrome P450 2C19 Genotype in a Large Nationwide Cohort of Acute Myocardial Infarction | Circulation](https://www.ahajournals.org/cms/asset/d73df6a8-7e32-44bb-abe9-43d33194eb93/zhc0051191420001.jpeg)
Clinical Events as a Function of Proton Pump Inhibitor Use, Clopidogrel Use, and Cytochrome P450 2C19 Genotype in a Large Nationwide Cohort of Acute Myocardial Infarction | Circulation
![PDF) Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy PDF) Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy](https://i1.rgstatic.net/publication/235681180_Expert_position_paper_on_the_use_of_proton_pump_inhibitors_in_patients_with_cardiovascular_disease_and_antithrombotic_therapy/links/00b7d527cd89681e60000000/largepreview.png)